Idioma:

Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment

Ahmed, Mohamed ; Cannon, Dara M ; Scanlon, Cathy ; Holleran, Laurena ; Schmidt, Heike ; McFarland, John ; Langan, Camilla ; McCarthy, Peter ; Barker, Gareth J ; Hallahan, Brian ; McDonald, Colm

Neuropsychopharmacology (New York, N.Y.), 2015-09, Vol.40 (10), p.2409-2417 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por

Enviar para

Título:
Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment
Autor: Ahmed, Mohamed ; Cannon, Dara M ; Scanlon, Cathy ; Holleran, Laurena ; Schmidt, Heike ; McFarland, John ; Langan, Camilla ; McCarthy, Peter ; Barker, Gareth J ; Hallahan, Brian ; McDonald, Colm
Assuntos: Adult ; Antipsychotic Agents - therapeutic use ; Antipsychotics ; Atrophy ; Atrophy - drug therapy ; Atrophy - etiology ; Case-Control Studies ; Cerebral Cortex - drug effects ; Cerebral Cortex - pathology ; Child, Preschool ; Clozapine - therapeutic use ; Female ; Follow-Up Studies ; Health sciences ; Humans ; Illnesses ; Image Processing, Computer-Assisted ; Longitudinal studies ; Magnetic Resonance Imaging ; Male ; Medical imaging ; Middle Aged ; Neuroimaging ; Original ; Patients ; Psychiatric Status Rating Scales ; Psychiatry ; Psychotropic drugs ; Regions ; Schizophrenia ; Schizophrenia - complications ; Schizophrenia - drug therapy ; Schizophrenia - pathology ; Statistics, Nonparametric ; Young Adult
É parte de: Neuropsychopharmacology (New York, N.Y.), 2015-09, Vol.40 (10), p.2409-2417
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: Despite evidence that clozapine may be neuroprotective, there are few longitudinal magnetic resonance imaging (MRI) studies that have specifically explored an association between commencement of clozapine treatment for schizophrenia and changes in regional brain volume or cortical thickness. A total of 33 patients with treatment-resistant schizophrenia and 31 healthy controls matched for age and gender underwent structural MRI brain scans at baseline and 6-9 months after commencing clozapine. MRI images were analyzed using SIENA (Structural Image Evaluation, using Normalization, of Atrophy) and FreeSurfer to investigate changes over time in brain volume and cortical thickness respectively. Significantly greater reductions in volume were detected in the right and left medial prefrontal cortex and in the periventricular area in the patient group regardless of treatment response. Widespread further cortical thinning was observed in patients compared with healthy controls. The majority of patients improved symptomatically and functionally over the study period, and patients who improved were more likely to have less cortical thinning of the left medial frontal cortex and the right middle temporal cortex. These findings demonstrate on-going reductions in brain volume and progressive cortical thinning in patients with schizophrenia who are switched to clozapine treatment. It is possible that this gray matter loss reflects a progressive disease process irrespective of medication use or that it is contributed to by switching to clozapine treatment. The clinical improvement of most patients indicates that antipsychotic-related gray matter volume loss may not necessarily be harmful or reflect neurotoxicity.
Editor: England: Nature Publishing Group
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment

Ahmed, Mohamed ; Cannon, Dara M ; Scanlon, Cathy ; Holleran, Laurena ; Schmidt, Heike ; McFarland, John ; Langan, Camilla ; McCarthy, Peter ; Barker, Gareth J ; Hallahan, Brian ; McDonald, Colm

England: Nature Publishing Group

Buscando em bases de dados remotas. Favor aguardar.